The Group cannot 
Last year the Group 
of the Group.
of the Group.
Director dealings in Group shares
Details of the Group’ s financial risk 
The Group 
of the Group.
Directors’ interests in the shares of the Group, including family and beneficial interests, at 31 July 2017 were: 
The remuneration of the Directors, who served on the Board of C4X Discovery Holdings plc during the year to 31 July 2017, is as follows:
Directors’ interests in share options to acquire ordinary shares of 1 pence in the Group as at 31 July 2017 were:
audited financial statements for the Group 
Details of the Group’ s financial risk 
the Group’ s and Company’ s share capital 
out the Group’ s financial risks and the 
the Group and Company financial statements.
to prepare the Group financial statements 
the Group and parent company financial 
•  the group financial statements have 
Materiality: Group financial statements £65,000 (2016: £51,000)
assets in the Group and the 
group.
Materiality for the group financial 
Group financial statements 
The loss for the year arises from the Group’ s continuing operations and is attributable to the equity holders of the parent.
Group
Group
Group
Group
These Group financial statements consolidate those of the Company and its subsidiaries (together referred to as the “Group” 
The financial statements of the Company and the Group for the year ended 31 July 2017 were authorised for issue by the Board 
of Directors on 14 December 2017 and the consolidated statement of financial position was signed on the Board’ s behalf by Clive Dix. The Company has elected to take the exemption under Section 408 of the Companies Act 2006 not to present the parent company’ s 
The Group’ s and parent company’ s financial statements have been prepared in accordance with International Financial Reporting Standards 
financial statements of the Group for the period ended 31 July 2017.
The Company and Group financial statements have been prepared on the historical cost basis.
Note 25 to the financial statements sets out the Group’ s financial risks and the management 
have continued to adopt the going concern basis in preparing the Group and Company financial statements.
of the Group’ s biotechnology-based business and need for ongoing investment in its drug development activities, the Group will be 
The preparation of financial statements requires management to make estimates and judgements that affect the amounts reported 
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
of the share price of C4XD and comparable companies, the Group’ s expected dividend yields, risk-free interest rates and expected lives 
The accounting policies set out below are consistent with those of the previous financial year and are applied consistently by Group entities.
The Group financial statements consolidate the financial statements of C4X Discovery Holdings plc and the entities it controls (its subsidiaries) 
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
At each reporting date the Group reviews the carrying value of its plant, equipment, intangible assets and goodwill to determine 
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
Financial assets and liabilities are recognised when the Group becomes party to the contracts that give rise to them and are classified as 
financial assets and liabilities at fair value through the consolidated statement of comprehensive income.
At the year end, the Group had no financial assets or liabilities designated at fair value through the consolidated statement 
•  they include no contractual obligations upon the Group to deliver cash or other financial assets or to exchange financial assets 
takes the legal form of the Company’ s own shares, the amounts presented in these financial statements for called up share capital and 
Company’ s financial statements as an increase in the value of the investment with a corresponding increase in equity via the share-based 
consolidated financial statements and those that are relevant to the Group are summarised below.
a significant effect on the consolidated financial statements of the Group in the period of initial application.
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
At 31 July 2017 the Group operated as one segment, being the provision of new technologies to improve the drug discovery process 
The Group
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
The Group
The Group
The Group
The Group
The Group has a deferred tax asset for share-based payments, for which the tax, measured at a standard rate of 17% (2016: 18%), 
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
The Group
The Group
The Group
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
The Group
Group
Group
Group
Group
Group
Group
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
Group
Group
The Group
The deferred shares of £1 carry no right to participate in dividends in respect of any financial year, until there shall have been paid to the 
in C4X Discovery Limited), being the estimated fair value of the shares on the day preceding the issue of the share options.
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
presented as a continuation of the C4X Discovery Limited accounts along with the share capital structure of the legal parent company 
Group
Group
This note presents information about the Group’ s exposure to various kinds of financial risks, the Group’ s objectives, policies 
report regularly to the Board on Group risk management.
The Group reviews its forecast capital requirements on a half-yearly basis to ensure that entities in the Group will be able to continue 
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
Group
Group
The Group’ s principal financial assets are cash, cash equivalents and deposits.
The Group
The Group
ANNUAL REPORT AND ACCOUNTS 2017 Notes to the financial statements continued
During the year, shareholder Aquarius Equity Partners Limited charged the Group £15,450 (2016: £15,450) for monitoring fees and were 
The Group